ArticleThe international journal of cardiovascular imaging2026
Significance of regional myocardial
Article in The international journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To investigate the prognostic significance of regional myocardial technetium-99m-pyrophosphate (99mTc-PYP) uptake distribution in patient with transthyretin amyloid cardiomyopathy (ATTR-CM). This single-center retrospective cohort study included patients diagnosed with wild-type ATTR-CM (ATTRwt) at the Hamamatsu University School of Medicine between August 2019 and May 2024. Regional 99mTc-PYP uptake was assessed using polar mapping across nine left (LV) and right (RV) ventricular segments. A total of 33 patients were analyzed with a median follow-up duration of 372 (range, 189–597) days. During the follow-up period, 17 patients experienced composite cardiovascular events (CCEs). Increased 99mTc-PYP uptake in both LV and RV segments was associated with a higher incidence of CCEs. The area under the curve (AUC) for predicting CCEs was 0.711 for National Amyloidosis Centre (NAC) staging alone, which increased to 0.824 and 0.809 when combined with the RV uptake score or RV basal free wall (RVBF) uptake ratio, respectively. The net reclassification improvement (NRI) for both parameters added to NAC staging was 0.669 (95% confidence interval [CI]: 0.027–1.312, p = 0.041). Similarly, the AUC for echocardiography-derived LV-global longitudinal strain (LV-GLS) alone was 0.743, which improved to 0.787 with the RV uptake score and 0.798 with the RVBF uptake ratio. Corresponding NRI values were 0.669 (95% CI: 0.027–1.312, p = 0.041) and 0.794 (95% CI: 0.172–1.416, p = 0.012). Incorporating the RV uptake score or RVBF uptake ratio significantly enhanced the predictive accuracy of outcome models based on NAC staging or LV-GLS in patients with ATTRwt.
Indexed as
Identifiers
41549187What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.